Human arginase and pegylated human arginase and the use thereof
US9109218B2 · kind B2 · utility
2Cited by
1References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 2012 |
| Grant date | Aug 18, 2015 |
| Priority date | — |
| Expiry date | Dec 23, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y305/03001
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a site-directed mutated arginase and the preparation method thereof, and the use of said site-directed mutated arginase in preparing a medicament for treating an arginase-related disease. The present invention also provides a pegylated arginase and the preparation method thereof, and the use of said pegylated arginase in preparing a medicament for treating an arginase-related disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.